Risk of infective endocarditis in patients with systemic lupus erythematosus in Taiwan: a nationwide population-based study

Abstract

Objectives

Patients with systemic lupus erythematosus are considered vulnerable to infective endocarditis and prophylactic antibiotics are recommended before an invasive dental procedure. However, the evidence is insufficient. This nationwide population-based study evaluated the risk and related factors of infective endocarditis in systemic lupus erythematosus.

Methods

We identified 12,102 systemic lupus erythematosus patients from the National Health Insurance research-oriented database, and compared the incidence rate of infective endocarditis with that among 48,408 non-systemic lupus erythematosus controls. A Cox multivariable proportional hazards model was employed to evaluate the risk of infective endocarditis in the systemic lupus erythematosus cohort.

Results

After a mean follow-up of more than six years, the systemic lupus erythematosus cohort had a significantly higher incidence rate of infective endocarditis (42.58 vs 4.32 per 100,000 person-years, incidence rate ratio = 9.86, p < 0.001) than that of the control cohort. By contrast, the older systemic lupus erythematosus cohort had lower risk (adjusted hazard ratio 11.64) than that of the younger-than-60-years systemic lupus erythematosus cohort (adjusted hazard ratio 15.82). Cox multivariate proportional hazards analysis revealed heart disease (hazard ratio = 5.71, p < 0.001), chronic kidney disease (hazard ratio = 2.98, p = 0.034), receiving a dental procedure within 30 days (hazard ratio = 36.80, p < 0.001), and intravenous steroid therapy within 30 days (hazard ratio = 39.59, p < 0.001) were independent risk factors for infective endocarditis in systemic lupus erythematosus patients.

Conclusions

A higher risk of infective endocarditis was observed in systemic lupus erythematosus patients. Risk factors for infective endocarditis in the systemic lupus erythematosus cohort included heart disease, chronic kidney disease, steroid pulse therapy within 30 days, and a recent invasive dental procedure within 30 days.

Keywords

Systemic lupus erythematosus infectious endocarditis dental procedure

Get full access to this article

View all access options for this article.

References

Tsokos

. Systemic lupus erythematosus. N Engl J Med 2011; 365: 2110–2121.

Roldan

Shively

Crawford

. An echocardiographic study of valvular heart disease associated with systemic lupus erythematosus. N Engl J Med 1996; 335: 1424–1430.

Thuny

Grisoli

Cautela

Riberi

Raoult

Habib

. Infective endocarditis: prevention, diagnosis, and management. Can J Cardiol 2014; 30: 1046–1057.

Abu-Shakra

Urowitz

Gladman

Gough

. Mortality studies in systemic lupus erythematosus. Results from a single center. I. Causes of death. J Rheumatol 1995; 22: 1259–1264.

Abu-Shakra

Urowitz

Gladman

Gough

. Mortality studies in systemic lupus erythematosus. Results from a single center. II. Predictor variables for mortality. J Rheumatol 1995; 22: 1265–1270.

Lin

Chang

Wang

. Coagulase-negative staphylococcus infective endocarditis in a lupus patient with Libman-Sacks endocarditis. J Heart Valve Dis 2015; 24: 236–238.

Azevedo

REUd

Rodrigues

ACT

França

LAd

Trindade

MLZHd

Vieira

MLC

Fischer

et al.

Endocardite por Streptococcus gallolyticus em portadora de lúpus eritematoso sistêmico: avaliação pelo ecocardiograma tridimensional. Einstein (São Paulo) 2013; 11: 373–375.

Bassetti

Nicco

Giacobbe

et al.

Bordetella holmesii endocarditis in a patient with systemic lupus erythematosus treated with immunosuppressive agents. J Chemother 2012; 24: 240–242.

Gobbi

Alba

Arvarellos

et al.

Bacterial endocarditis caused by salmonella in systemic lupus erythematosus. Rev Fac Cien Med Univ Nac Cordoba 2011; 68: 25–29.

10.

Armstrong

Wright

McVeigh

Finch

. Infective endocarditis complicating rituximab (anti-CD20 monoclonal antibody) treatment in an SLE patient with a past history of Libman–Sacks endocarditis: a case for antibiotic prophylaxis? Clin Rheumatol 2006; 25: 583–584.

11.

Liao

C-H

Yao

T-C

Chung

H-T

Lien

R-I

Huang

J-L

. Staphylococcal endocarditis and multiple emboli in a patient with systemic lupus erythematosus. J Rheumatol 2004; 31: 2305–2306.

12.

Tikly

Diese

Zannettou

Essop

. Gonococcal endocarditis in a patient with systemic lupus erythematosus. Br J Rheumatol 1997; 36: 270–272.

13.

Miller

Egan

Falace

Rayens

Moore

. Prevalence of infective endocarditis in patients with systemic lupus erythematosus. J Am Dent Assoc 1999; 130: 387–392.

14.

Hochberg

. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725–1725.

15.

Zysset

Montgomery

Redding

Dell’Italia

. Systemic lupus erythematosus: a consideration for antimicrobial prophylaxis. Oral Surg, Oral Med, Oral Pathol 1987; 64: 30–34.

16.

Thanavaro

Nixon

. Endocarditis 2014: An update. Heart Lung 2014; 43: 334–337.

17.

Sherman-Weber

Axelrod

Suh

et al.

Infective endocarditis following orthotopic heart transplantation: 10 cases and a review of the literature. Transplant Infect Dis 2004; 6: 165–170.

18.

Veloso

Amiguet

Rousson

et al.

Induction of experimental endocarditis by continuous low-grade bacteremia mimicking spontaneous bacteremia in humans. Infect Immun 2011; 79: 2006–2011.

19.

Lockhart

Brennan

Sasser

Fox

Paster

Bahrani-Mougeot

. Bacteremia associated with toothbrushing and dental extraction. Circulation 2008; 117: 3118–3125.

20.

Habib

Lancellotti

Antunes

et al.

2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Eur Heart J 2015; 36: 3075–3128.

21.

Wilson

Taubert

Gewitz

et al.

American Heart Association guideline: Prevention of infective endocarditis. Circulation 2007; 116: 1736–1754.